BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34868928)

  • 1. Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study.
    Buja A; Bardin A; Damiani G; Zorzi M; De Toni C; Fusinato R; Spina R; Vecchiato A; Del Fiore P; Mocellin S; Baldo V; Rugge M; Rossi CR
    Front Oncol; 2021; 11():737399. PubMed ID: 34868928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could the mitotic count improve personalized prognosis in melanoma patients?
    Buja A; Rugge M; Cozzolino C; Dossi F; Zorzi M; Vecchiato A; de Luca G; Del Fiore P; Tropea S; dall'Olmo L; Rossi CR; Boccuzzo G; Mocellin S
    PLoS One; 2024; 19(4):e0302309. PubMed ID: 38626072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
    Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
    J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
    [No Abstract]   [Full Text] [Related]  

  • 4. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
    Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
    Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
    Huang K; Fan J; Misra S
    J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
    Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor location predicts survival in cutaneous head and neck melanoma.
    Tseng WH; Martinez SR
    J Surg Res; 2011 May; 167(2):192-8. PubMed ID: 21176922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Melanoma: Direct Costs by Clinical and Pathological Profile.
    Buja A; Rugge M; De Luca G; Zorzi M; De Toni C; Cozzolino C; Vecchiato A; Del Fiore P; Tropea S; Spina R; Baldo V; Rossi CR; Mocellin S
    Dermatol Ther (Heidelb); 2022 May; 12(5):1157-1165. PubMed ID: 35426606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.
    Ma Q; Suo H; Zhu L; Qian Y; Sun X; Xie J; Li Q; Fu Y; Li J; Tao J
    Cancer Med; 2020 Jul; 9(13):4561-4571. PubMed ID: 32367684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
    Bailey CN; Martin BJ; Petkov VI; Schussler NC; Stevens JL; Bentler S; Cress RD; Doherty JA; Durbin EB; Gomez SL; Gonsalves L; Hernandez BY; Liu L; Morawski BM; Schymura MJ; Schwartz SM; Ward KC; Wiggins C; Wu XC; Goldberg MS; Siegel JJ; Cook RW; Covington KR; Kurley SJ
    JCO Precis Oncol; 2023 Jun; 7():e2300044. PubMed ID: 37384864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
    Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
    J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
    Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Wide Local Excision on Melanoma Patient Survival: A Population-Based Study.
    Buja A; Rugge M; Damiani G; De Luca G; Zorzi M; Fusinato R; De Toni C; Vecchiato A; Del Fiore P; Falasco F; Spina R; Rossi CR; Mocellin S
    Front Public Health; 2022; 10():806934. PubMed ID: 35433570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
    Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
    Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in cutaneous malignant melanoma and its association with Neutrophil-to-Lymphocyte ratio.
    Pinto-Paz ME; Cotrina-Concha JM; Benites-Zapata VA
    Cancer Treat Res Commun; 2021; 29():100464. PubMed ID: 34598061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.